| Term 
 
        | Where is calcium found in the body? |  | Definition 
 
        | In the bones and teeth Protein bound to albumin, complexed (citrate), or majority is ionized
 |  | 
        |  | 
        
        | Term 
 
        | What hormones/compounds regulate calcium? |  | Definition 
 
        | - PTH - Promotes bone resorption when calcium is low. Promotes Ca reabsorption and phosphate excretion, formation of calcitriol - Vit D - Increased GI absorption of calcium, renal reabsorption. Works with PTH
 - Calcitonin - counteracts PTH. When calcium is HIGH - storage in bones or excretion.
 |  | 
        |  | 
        
        | Term 
 
        | What is calcitonin secreted by? |  | Definition 
 
        | Parafollicular cells of the thyroid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Parathyroid gland(s) on the back of the thyroid, specifically chief cells |  | 
        |  | 
        
        | Term 
 
        | Is calcium absorption efficient? |  | Definition 
 
        | No, 90% lost through fecal excretion. But, the kidney can reabsorb calcium based on PTH levels and Ca levels.
 |  | 
        |  | 
        
        | Term 
 
        | What cells affect bones and calcium? |  | Definition 
 
        | Osteoblasts - mineralize/build bone Osteroclasts - demineralize bone
 PTH low - kidneys excrete calcium and osteoblasts mineralize bone
 PTH high - Kidneys reabsorb and osteoclasts demineralize bone.
 |  | 
        |  | 
        
        | Term 
 
        | How is phosphate dealt with in the body? |  | Definition 
 
        | 80% in bone, key regulator of energy Absorption is Vit D dependent
 ** In bone - complexed w/ calcium to form hydroxyapatite crystals
 |  | 
        |  | 
        
        | Term 
 
        | What is the function of PTH? |  | Definition 
 
        | Maintain plasma calcium and phosphate levels by: - increasing bone resorption to mobilize calcium, excrete phosphate
 - Acts via GPCRs: PTHR1 and 2.
 ** Intermittent activity: Osteoblasts. The MoA of Teriparatide/Forteo
 ** Chronic activity: osteoclasts
 |  | 
        |  | 
        
        | Term 
 
        | What is the MoA of Teriperatide/Forteo? |  | Definition 
 
        | Intermittant action of PTH - stimulate osteoblasts human PTH fragment.
 |  | 
        |  | 
        
        | Term 
 
        | How does the body tell when it needs calcium? |  | Definition 
 
        | Calcium sensing receptor senses calcium levels. Increased calcium --> PKC pathway and PTH inhibition. ** Low calcium --> PKA pathway and PTH activation. Osteoclasts, Ca reabsorption, Pi excretion. Vit D activates.
 |  | 
        |  | 
        
        | Term 
 
        | How is osteoclast activity mediated? |  | Definition 
 
        | Binding of RANKL to RANK --> Osteoclast activation. PTH increases RANKL, decr OPG **OPG inhibits RANKL. If RANKL is inhibited, so are osteoclasts.
 |  | 
        |  | 
        
        | Term 
 
        | How does PTH reabsorb calcium renally? |  | Definition 
 
        | Upregulates calcium channels in the lumen. Calcium binds to calbindin --> diffusion. Transport out of cell by Na/Ca antiporter and Ca-atpase |  | 
        |  | 
        
        | Term 
 
        | What role does Vit D play with calcium? |  | Definition 
 
        | UV converts to calcitriol. Calcitriol augments absorption of calcium and phosphate - Works w/ PTH to reduce renal excretion.
 **Ca decreases --> surge in D3
 **Enhanced calcium reabsorption in the intestine
 |  | 
        |  | 
        
        | Term 
 
        | What is the role of calcitonin in calcium regulation? |  | Definition 
 
        | When calcium is high, brings calcium down. Action opposes PTH. Binds to and inhibits osteoclasts.
 Blocks renal reabsorption of calcium --> excretion
 |  | 
        |  | 
        
        | Term 
 
        | What drugs are Vit D analogues? |  | Definition 
 
        | - Calcitriol/Calcijex or Rocaltrol. - active - Doxyercalciferol/Hectorol - a prodrug, activated by hydroxylation
 - Dihydrotachysterol/Roxane - reduced vD2, converted by the liver
 - 1OHD/One Alpha - already hydroxylated, hepatically activated
 |  | 
        |  | 
        
        | Term 
 
        | What do Vit D analogues require for activity? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How does a decrease in estrogen affect bones? |  | Definition 
 
        | Increased bone resorption, decreased formation. ERalpha mediated. Low blood Ca triggers catabolism.
 |  | 
        |  | 
        
        | Term 
 
        | What is the med-chem of bisphosphonates? |  | Definition 
 
        | All have a P-C-P backbone that can chelate cations such as calcium: affinity for bone surfaces. **2nd gen contains nitrogen: Inhibits FPPS, farnesol, geranylgeraniol required for prenylation.
 |  | 
        |  | 
        
        | Term 
 
        | What is the MoA of bisphosphonates? |  | Definition 
 
        | Inhibit osteoclast formation - induce apoptosis Limit bone turnover, allowing osteoBLASTS to form.
 2nd gen - inhibition of cholesterol pathway
 |  | 
        |  | 
        
        | Term 
 
        | What are 1st generation bisphosphonates? |  | Definition 
 
        | - Etidronate/Didronel - Tiludronate/Skelid
 **Used for Paget's disease
 |  | 
        |  | 
        
        | Term 
 
        | What are 2nd generation bisphosphonates? |  | Definition 
 
        | - Pamidrone/Aredia - Alendronate/Fosamax
 - Ibandronate/Boniva
 **Along with inducing apoptosis, inhibits prenylation necessary for osteoclast proliferation.
 HIGH affinity for hydroxyapatite crystals
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incorporation of a farnesyl or geranylgeraniol - long fatty acids - into a GPCR |  | 
        |  | 
        
        | Term 
 
        | How do bisphosphonates induce apoptosis? |  | Definition 
 
        | Inhibition of FPP synthase --> Isopentanyl pyrophosphate precursor builds up --> APPPL, which is toxic to osteoclasts. |  | 
        |  | 
        
        | Term 
 
        | What are 3rd generation bisphosphonates? |  | Definition 
 
        | - Risendronate/Actonel - Zolendronate/Reclast
 **Aryl rings w/ Nitrogen. Can be renally toxic.
 |  | 
        |  | 
        
        | Term 
 
        | What are bisphosphonate considerations? |  | Definition 
 
        | - All are poorly bioavailable, better w/ generation - DO NOT TAKE W/ FOOD. Drink with non-mineral water. Separate from other medications.
 - Excreted by kidneys
 - Causes heartburn --> remain upright.
 - ONJ with some agents
 |  | 
        |  | 
        
        | Term 
 
        | What is Raloxifene/Evista? |  | Definition 
 
        | A SERM, analogue of tamoxifen. Agonist at bone/CV
 Antagonist at breast and uterus
 **Decreased resorption, increased BMD, decreased fracture risk.
 |  | 
        |  | 
        
        | Term 
 
        | What are the steps of bone remodeling? |  | Definition 
 
        | 1) Activation - pre-osteoclasts stimulated to mature 2) Resorption - Digestion of old bone
 3) Reversal - end of resorption
 4) Formation - Synthesis of new matrix
 5) Quiescence - Blasts become bone lining on new surface
 |  | 
        |  | 
        
        | Term 
 
        | What do vertebral fractures lead to? |  | Definition 
 
        | - Kyphosis - outward curvature of thoracic region - Lordosis - forward curvature of lumbar and cervical regions
 |  | 
        |  | 
        
        | Term 
 
        | What are the classifications of OP? |  | Definition 
 
        | - Primary - age related or post-menopausal - Secondary - due to medical disorders or medication
 |  | 
        |  | 
        
        | Term 
 
        | What are MAJOR risk factors for OP? |  | Definition 
 
        | Modifiable: Smoking, low BMI, low BMD Non-modifiable: Female, short, white/asian, advanced age
 |  | 
        |  | 
        
        | Term 
 
        | What is the most common medication that causes OP? |  | Definition 
 
        | Glucocorticoids: Steroids > 5 mg/day for 3 months. |  | 
        |  | 
        
        | Term 
 
        | What are risk factors for falls? |  | Definition 
 
        | Medical: H/x, weakness, poor vision, dehydration, dementia, sedating medication Environmental: Lack of assistance, poor lighting, obstacles
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A T-score - mean SDV from young adult female. - normal - -1.0 and above
 - osteopenia - -1.0 to -2.5
 - osteoporosis - -2.5 or below.
 **can only use this on post-menopausal women
 |  | 
        |  | 
        
        | Term 
 
        | Who is indicated for BMD scanning? |  | Definition 
 
        | - Women > 65 - Men > 70
 - Adults at risk for fracture
 **FRAX - 10 year probability of hip fracture for post-menopausal women
 |  | 
        |  | 
        
        | Term 
 
        | What can be done to prevent OP? |  | Definition 
 
        | - Limit caffeine and sodium - Limit alcohol, stop smoking
 - Avoid low-protein
 - Calcium essential for prevention and Tx
 |  | 
        |  | 
        
        | Term 
 
        | What is the clinical presentation of OP? |  | Definition 
 
        | - T score of -2.5 or below - Hip or vertebral fracture
 - Height loss
 |  | 
        |  |